Cargando…
Pediococcus acidilactici pA1c(®) Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota
Type 2 diabetes (T2D) is a complex metabolic disease, which involves maintained hyperglycemia, mainly due to the development of an insulin resistance process. Metformin administration is the most prescribed treatment for diabetic patients. In a previously published study, we demonstrated that Pedioc...
Autores principales: | Cabello-Olmo, Miriam, Oneca, María, Urtasun, Raquel, Pajares, María J., Goñi, Saioa, Riezu-Boj, José I., Milagro, Fermín I., Ayo, Josune, Encio, Ignacio J., Barajas, Miguel, Araña, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143274/ https://www.ncbi.nlm.nih.gov/pubmed/37111688 http://dx.doi.org/10.3390/pharmaceutics15041203 |
Ejemplares similares
-
Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice
por: Cabello-Olmo, Miriam, et al.
Publicado: (2022) -
Pediococcus acidilactici CECT9879 (pA1c) Counteracts the Effect of a High-Glucose Exposure in C. elegans by Affecting the Insulin Signaling Pathway (IIS)
por: Yavorov-Dayliev, Deyan, et al.
Publicado: (2022) -
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice
por: Yavorov-Dayliev, Deyan, et al.
Publicado: (2023) -
Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
por: Riezu-Boj, José I., et al.
Publicado: (2022) -
Role of Postbiotics in Diabetes Mellitus: Current Knowledge and Future Perspectives
por: Cabello-Olmo, Miriam, et al.
Publicado: (2021)